Stock News

Breaking Down the Numbers: HomeTrust Bancshares Inc. Reports Strong Financial Performance for Q4 2024 and Declares Quarterly Dividend! ASHEVILLE, N.C., Jan. 23, 2025 (GLOBE NEWSWIRE) — HomeTrust Bancshares, Inc. (NASDAQ: HTBI) Preliminary Net Income for Q4 2024 and Quarterly Cash Dividend Approval HomeTrust Bancshares Inc., the holding company of HomeTrust

Breaking News: Nokia Buys Back Its Own Shares in Bold Move for 2025! Overview Nokia Corporation made a significant move by repurchasing its own shares on 22 January 2025. The decision was part of a share buyback program initiated by the company’s Board of Directors to counter the dilutive effect

Attention AstraZeneca PLC Investors: Don’t Miss Out on Important Deadline for Securities Class Action Rosen, a Top National Firm, Urges You to Seek Counsel Now! NEW YORK, NY / ACCESS Newswire / January 22, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities

Attention Shareholders: Important Update on Micron Technology Inc. Investment Losses and Upcoming Deadlines – A Reminder from Pomerantz Law Firm New York, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Micron Technology, Inc. (“Micron” or the “Company”)

Valneva’s Chikungunya Vaccine Shows Promise in Children: Phase 2 Results and Phase 3 Dose Decision Announced! Saint-Herblain (France), January 22, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced positive results for its Phase 2 clinical trial evaluating the safety and immunogenicity of two different dose levels of

AI Reveals: Should You Invest in NVIDIA or Palantir for 2025 and Beyond? Overview: Despite their differences, Nvidia (NASDAQ: NVDA) and Palantir (NASDAQ: PLTR) have much in common. Both stocks enjoy significant investor optimism, both companies have been major players in the ongoing artificial intelligence (AI) boom, and both firms

Join the Fight for Justice with Bronstein, Gewirtz & Grossman LLC Today! Revance Stockholders Alert New York, NY / ACCESS Newswire / January 22, 2025 Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, is calling on all Revance Therapeutics, Inc. (RVNC) stockholders to join the fight for justice.

Breaking Down the Numbers: Greene County Bancorp Inc. Sees 31% Increase in Net Income for Q4 2024! CATSKILL, N.Y., Jan. 22, 2025 (GLOBE NEWSWIRE) — Greene County Bancorp, Inc. (NASDAQ: GCBC) The Company’s Financial Performance Greene County Bancorp, Inc. has recently announced a significant increase in net income for the

Boosting Finances: Cobalt Blue Completes Entitlement Issue and Secures Strong Financial Future! Cobalt Blue Holdings Ltd Bolsters Finances Cobalt Blue Holdings Ltd has bolstered its finances by A$519,647 ahead of a key year in its critical minerals strategy after closing a pro-rata non-renounceable offer to eligible shareholders. The offer was

Introducing Red Light Holland’s New CFO: Keith Li and Exciting Corporate Updates! Toronto, Ontario–(Newsfile Corp. – January 22, 2025) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or the “Company”), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and

Breaking News: Dermata Therapeutics Secures $255 Million in Private Placement Under NASDAQ Rules! SAN DIEGO, CA / ACCESS Newswire / January 22, 2025 Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, has announced that it has entered into

Unleashing the Latest Market Insights: Proactive Investors Keeps You Ahead of the Game! Sun newspaper owner News Corp (NASDAQ:NWSA) Issues Apology to Prince Harry In a surprising turn of events, News Corp, the owner of the Sun newspaper, has issued a public apology to Prince Harry as part of their

Breaking News: Azul’s Exchange Offers and Consent Solicitations Reach Exciting Conclusion! SÃO PAULO, Jan. 22, 2025 /PRNewswire Azul S.A., “Azul,” (B3: AZUL4) (NYSE: AZUL) (“Azul”) today announces the expiration and final results of the previously announced (i) offers by its wholly-owned subsidiary Azul Secured Finance LLP (the “Issuer”) to Eligible

Revolutionizing the Market: Orthocell’s Remplir Sales Skyrocket, Fueling Global Expansion Description Buoyed by early sales traction for Remplir™ described as “outstanding”, Orthocell Ltd is accelerating its global commercial expansion strategy into multiple key jurisdictions ahead of US FDA clearance which is expected in March/April 2025. The sales growth in the